Skip to search formSkip to main contentSkip to account menu

ED 110

Known as: ED-110 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
DNA topoisomerase I has been shown to be an important therapeutic target in cancer chemotherapy for the camptothecins as well as… 
Highly Cited
1993
Highly Cited
1993
ED-110 is a new semisynthetic antitumor agent derived from a novel indolocarbazole antibiotic, BE-13793C, produced by an… 
1993
1993
A new indolocarbazole compound, ED‐110, which was obtained by glucosylating a microbial product (BE‐13793C) and is a potent… 
1992
1992
^TV-dimethylformamide (DMF, 37 ml) was added potassium carbonate (510mg, 3.69mmol) and benzyl bromide (170^1, 1.43mmol) at room…